Lichen China Limited (LICN) Income Statement Analysis

See more : Zinnwald Lithium Plc (ZNWLF) Income Statement Analysis – Financial Results

Complete financial analysis of Lichen China Limited (LICN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lichen China Limited, a leading company in the Specialty Business Services industry within the Industrials sector.

You may be interested

Shanghai Chlor-Alkali Chemical Co., Ltd. (600618.SS) Income Statement Analysis – Financial Results
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) Income Statement Analysis – Financial Results
Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) Income Statement Analysis – Financial Results
Racing Force S.P.A. (ALRFG.PA) Income Statement Analysis – Financial Results
M Winkworth PLC (WINK.L) Income Statement Analysis – Financial Results

Lichen China Limited (LICN)

Industry: Specialty Business Services

Sector: Industrials

Website: https://www.lichenzx.com

About Lichen China Limited

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sale of teaching and learning materials. It also provides Lichen Education Accounting Practice System V1.0, a financial and taxation training software, and academic affairs management system to partnered institutions under the partnership agreements, as well as offers software installation, training, and after sales technical and maintenance support services. The company was founded in 2004 and is based in Jinjiang, China. Lichen China Limited operates as a subsidiary of Silver Sky Investment Limited

Metric	2023	2022	2021	2020	2019	2017	2016	2015	2014
Revenue	39.76M	33.81M	34.30M	30.67M	31.60M	25.58M	20.78M	14.76M	9.27M
Cost of Revenue	15.44M	13.61M	13.82M	11.83M	12.26M	7.35M	5.61M	4.23M	3.07M
Gross Profit	24.32M	20.19M	20.48M	18.84M	19.34M	18.24M	15.17M	10.53M	6.19M
Gross Profit Ratio	61.17%	59.73%	59.70%	61.42%	61.21%	71.28%	73.02%	71.34%	66.84%
Research & Development	0.00	1.06M	1.08M	930.00K	0.00	620.13K	397.38K	396.65K	389.34K
General & Administrative	8.94M	7.43M	7.17M	8.46M	7.87M	0.00	0.00	0.00	0.00
Selling & Marketing	3.12M	2.11M	2.01M	1.59M	1.75M	0.00	0.00	0.00	0.00
SG&A	12.06M	9.54M	9.18M	10.05M	9.62M	8.31M	6.15M	4.74M	3.35M
Other Expenses	0.00	34.00K	188.00K	106.00K	0.00	0.00	0.00	0.00	0.00
Operating Expenses	12.04M	9.54M	9.18M	10.05M	9.62M	8.93M	6.55M	5.14M	3.74M
Cost & Expenses	27.50M	23.16M	23.00M	21.88M	21.88M	16.28M	12.15M	9.37M	6.81M
Interest Income	38.00K	60.00K	28.00K	103.00K	49.00K	31.52K	17.76K	11.61K	6.49K
Interest Expense	0.00	0.00	0.00	0.00	49.00K	0.00	0.00	0.00	0.00
Depreciation & Amortization	2.92M	2.66M	2.45M	2.25M	2.19M	457.22K	305.26K	202.06K	93.48K
EBITDA	15.18M	11.35M	12.05M	9.59M	11.97M	9.82M	8.96M	5.62M	2.56M
EBITDA Ratio	38.19%	39.43%	40.08%	35.70%	37.71%	38.16%	42.98%	37.89%	27.52%
Operating Income	12.26M	10.65M	11.30M	8.79M	9.73M	9.30M	8.63M	5.39M	2.46M
Operating Income Ratio	30.83%	31.50%	32.94%	28.65%	30.78%	36.37%	41.52%	36.52%	26.51%
Total Other Income/Expenses	-671.00K	94.00K	216.00K	209.00K	5.00K	59.18K	23.93K	28.96K	6.49K
Income Before Tax	11.59M	10.74M	11.51M	9.00M	9.73M	9.36M	8.65M	5.42M	2.46M
Income Before Tax Ratio	29.15%	31.78%	33.57%	29.33%	30.80%	36.60%	41.63%	36.72%	26.58%
Income Tax Expense	3.25M	2.92M	3.05M	2.59M	2.66M	2.86M	2.42M	1.46M	641.71K
Net Income	8.34M	7.82M	8.46M	6.41M	7.07M	6.51M	5.82M	3.96M	1.82M
Net Income Ratio	20.97%	23.13%	24.67%	20.89%	22.37%	25.43%	28.00%	26.85%	19.67%
EPS	0.32	0.35	0.29	0.22	0.25	0.23	0.20	0.14	0.06
EPS Diluted	0.32	0.35	0.29	0.22	0.25	0.23	0.20	0.14	0.06
Weighted Avg Shares Out	26.07M	22.50M	28.75M	28.75M	28.75M	28.75M	28.75M	28.75M	28.75M
Weighted Avg Shares Out (Dil)	26.07M	22.50M	28.75M	28.75M	28.75M	28.75M	28.75M	28.75M	28.75M

Lichen China Limited Announced Financial Results for Fiscal Year 2023

April 5, 2024prnewswire.com

XIAMEN, China , April 5, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ: LICN), a dedicated financial and taxation service provider in China, today announced its financial results for the fiscal year ended December 31, 2023. FY 2023...

Lichen China Limited Launches AI-Powered Software for Financial & Taxation Solutions

March 25, 2024prnewswire.com

XIAMEN, China , March 25, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ: LICN), a dedicated financial and taxation service provider in China, today announced the launch of AI-powered software - Lichen AI Robot, which was developed on GPT-based technology. Lichen AI...

Lichen China Limited Expands Presence in International Markets

March 14, 2024prnewswire.com

XIAMEN, China, March 14, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ:LICN), a dedicated financial and taxation service provider in China, today announced its expansion into international markets. Lichen China established its subsidiary in Singapore ("Lichen Singapore") in December 2023 and...

Lichen China Limited Announces Appointment of Robert Bodenstein to Board of Directors

February 27, 2024prnewswire.com

XIAMEN, China , Feb. 27, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ:LICN), a dedicated financial and taxation service provider in China, announced the appointment of Mr. Robert Bodenstein to its board of directors, effective February 26, 2024.